1. Evaluating Plasma Pharmacokinetics of Intravenous Iron Formulations: Judging Books by Their Covers?

   • Amy Barton Pai

   Commentary 02 December 2014 Pages: 323 - 324

2. Oral Bioavailability: Issues and Solutions via Nanoformulations

   • Kamla Pathak
   • Smita Raghuvanshi

   Review Article 11 February 2015 Pages: 325 - 357

   

3. Placental Transfer of Antidepressant Medications: Implications for Postnatal Adaptation Syndrome

   • Grace Ewing
   • Yekaterina Tatarchuk
   • Deborah Kim

   Review Article 25 February 2015 Pages: 359 - 370

4. A Review of Pharmacokinetic Drug–Drug Interactions with the Anthelmintic Medications Albendazole and Mebendazole

   • Shane Ashley Pawluk
   • Craig Allan Roels
   • Mary H. H. Ensom

   Review Article 18 February 2015 Pages: 371 - 383

5. Population Pharmacokinetic Meta-Analysis to Bridge Ferumoxytol Plasma Pharmacokinetics Across Populations

   • Nele Plock
   • Axel Facius
   • Pau Aceves

   Original Research Article Open access 05 November 2014 Pages: 385 - 395

   

6. Population Pharmacokinetic-Pharmacodynamic Modelling of 24-h Diastolic Ambulatory Blood Pressure Changes Mediated by Axitinib in Patients with Metastatic Renal Cell Carcinoma

   • Ying Chen
   • Brian I. Rini
   • Yazdi K. Pithavala

   Original Research Article 25 October 2014 Pages: 397 - 407

   

7. Comparing Dosage Adjustment Methods for Once-Daily Tobramycin in Paediatric and Adolescent Patients with Cystic Fibrosis

   • Stefanie Hennig
   • Franziska Holthouse
   • Christine E. Staatz

   Original Research Article 18 November 2014 Pages: 409 - 421

   

8. Influence of Sex and Race on Mycophenolic Acid Pharmacokinetics in Stable African American and Caucasian Renal Transplant Recipients

   • Kathleen M. Tornatore
   • Calvin J. Meaney
   • Rocco C. Venuto

   Original Research Article 16 December 2014 Pages: 423 - 434

   

9. Population Pharmacokinetic Modeling of Thymoglobulin^® in Children Receiving Allogeneic-Hematopoietic Cell Transplantation: Towards Improved Survival Through Individualized Dosing

   • Rick Admiraal
   • Charlotte van Kesteren
   • Catherijne A. J. Knibbe

   Original Research Article 03 December 2014 Pages: 435 - 446

   

10. Comment on: “Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus”

    • Emanuel Raschi
    • Elisabetta Poluzzi
    • Fabrizio De Ponti

    Letter to the Editor 27 February 2015 Pages: 447 - 448

11. Author’s Reply to De Ponti et al.: “Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus”

    • André J. Scheen

    Letter to the Editor 27 February 2015 Pages: 449 - 451

12. Erratum to: Kinetically Guided Neoadjuvant Chemoradiotherapy Based on 5-Fluorouracil in Patients with Locally Advanced Rectal Cancer

    • Jiří Grim
    • Miloš Hroch
    • Jiřina Martínková

    Erratum 20 March 2015 Pages: 453 - 453

13. Erratum to: Application of Modeling and Simulation to a Long-Term Clinical Trial: A Direct Comparison of Simulated Data and Data Actually Observed in Japanese Osteoporosis Patients Following 3-Year Ibandronate Treatment

    • Kiyohiko Nakai
    • Satofumi Iida
    • Takehiko Kawanishi

    Erratum 20 March 2015 Pages: 455 - 455